about
Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatmentAltered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease.Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular diseaseHistochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat ColonRosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.Quantitative evaluation of myenteric ganglion cells in normal human left colon: implications for histopathological analysis.An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction?Role of cyclooxygenase isoforms and nitric-oxide synthase in the modulation of tracheal motor responsiveness in normal and antigen-sensitized Guinea pigs.Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase.Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation.Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 Plays a Role in the Impairing Effects of Cyclooxygenase Inhibitors on Gastric Ulcer HealingResistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibitionCyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II–Infused Mice
P50
Q27318090-D00BFC48-F447-4CFD-ABCD-3CE572F20A75Q31111701-44075369-2362-4D71-B991-85E5EC707B04Q34025182-4CC5FFE5-5AC7-4546-B5BE-78EF423F70D9Q35870335-726A7B77-AAB3-48E4-BCC9-8E10348C397FQ36929431-0A237FDD-2ABD-4A3E-ACA5-6E331AC186CDQ37002601-16E7452B-67E9-41AA-AC70-4DA6B527480EQ38422237-A8CB2C99-3F74-4C89-87A5-B4F91FC0B1BFQ39901570-FBFA57CF-9F11-406D-BD23-52C461357DEDQ42485284-3C402A3A-838D-4AB1-BFD8-9319EBF804EDQ44845003-02298561-8D91-467B-A465-834616ACF3F1Q46621396-F8279D1A-E29B-4E30-87DE-8B9720110433Q46693066-BDF37F93-39DB-44FA-9A9F-762ABB695ADCQ50939239-03D407BE-F795-4025-92EF-AECFD4C5DCD6Q61807419-464C540C-884B-403D-BB8C-AAD25334ED6DQ61807425-E7839604-2356-4E55-9CC9-6AE57588D7F6Q61807435-7DBD341A-36D6-46BD-820E-5BA99A17FA33
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Chiara Ippolito
@ast
Chiara Ippolito
@en
Chiara Ippolito
@es
Chiara Ippolito
@nl
Chiara Ippolito
@sl
type
label
Chiara Ippolito
@ast
Chiara Ippolito
@en
Chiara Ippolito
@es
Chiara Ippolito
@nl
Chiara Ippolito
@sl
prefLabel
Chiara Ippolito
@ast
Chiara Ippolito
@en
Chiara Ippolito
@es
Chiara Ippolito
@nl
Chiara Ippolito
@sl
P214
P106
P1153
55945744100
P21
P214
P31
P396
IT\ICCU\CFIV\263720
P496
0000-0001-8671-313X
P569
1977-01-01T00:00:00Z
P734
P735
P7859
viaf-307340818